How has been the historical performance of Maitreya Medica.?

Answer:The historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years. Breakdown: Maitreya Medica's net sales have seen a decline from 49.41 Cr in Mar'22 to 46.66 Cr in Mar'25, with a peak in Mar'24 at 47.80 Cr. Total operating income followed a similar trend, peaking at 49.41 Cr in Mar'22 and dropping to 46.66 Cr in Mar'25. The total expenditure, excluding depreciation, decreased from 46.05 Cr in Mar'22 to 41.80 Cr in Mar'25, contributing to an operating profit (PBDIT) that rose from 3.36 Cr in Mar'22 to 4.86 Cr in Mar'25, although it was higher at 7.25 Cr in Mar'23. Profit before tax also fluctuated, reaching 3.21 Cr in Mar'25, down from 5.93 Cr in Mar'23. Consequently, profit after tax decreased from 4.25 Cr in Mar'23 to 1.87 Cr in Mar'25. The company's total assets increased from 24.49 Cr in Mar'22 to 47.99 Cr in Mar'25, while total liabilities rose from 24.49 Cr to 47.99 Cr in the same period. Cash flow from operating activities improved significantly to 5.00 Cr in Mar'25 from a negative 2.00 Cr in Mar'24, indicating better cash management. Overall, Maitreya Medica has shown a mixed performance with some growth in assets and cash flow, but declining sales and profits in recent years.